Recent studies show that miR-622 is associated with tumor metastatic capability in gastric cancers [57] and can suppress glioma invasion and migration by directly targeting activating transcription factor ATF2 [58], but no data have been released about a miR-622 neuromodulation activity. Here, ATF2 is linked to central nervous system cancer.